Alzheimer's Degenerative Disease

Good Essays
Alzheimer’s is a common neurodegenerative disease that accounts for the majority of all cases of dementia (Advokat, Comaty & Julien, 2014). Although the exact cause of Alzheimer’s is unknown, it is hypothesized that two systems crucial for the communication between brain cells fail due to the down regulation of acetylcholine and the over activation of glutamate, which result in the death of neurons (IOS Press, 2008). It is believed to involve the irreversible loss of cholinergic neurons, specifically in the cerebral cortex and hippocampus (Advokat et al., 2014). The onset of this disease usually occurs after age 60, but is increasingly being reported in people younger than 65 (Advokat et al., 2014). Symptoms of Alzheimer’s involve cognitive …show more content…
The definitive diagnosis of Alzheimer’s can’t be made until autopsy, when neuronal loss, accumulation of beta-amyloid plaques, neurofibrillary tangles and abnormal tau microtubules are observed (Advokat et al., 2014). The current drugs that treat Alzheimer’s act on brain neurotransmitters, but do not alter the course of the disease (Advokat et al., 2014). Some of the drugs for the treatment of Alzheimer’s disease focus on inhibiting the enzyme that breaks down acetylcholine in the synapse called acetyl cholinesterase inhibitors (Advokat et al., 2014). Donepezil, galantamine, and rivastigmine are examples of acetyl cholinesterase inhibitors (AChE-Is) that are currently prescribed to patients suffering from Alzheimer’s disease (Hansen et al., 2008). Side effects associated with these AChE-Is include nausea, diarrhea, abdominal cramping and anorexia (Advokat et al., 2014). These drugs are problematic because they are usually only associated with a very small improvement in cognitive improvement from baseline. These improvements do not remain constant and patients’ cognitive symptoms get increasingly worse as the disease …show more content…
Acetylcholine is a neurotransmitter, which plays a role in synaptic plasticity, learning and memory. It has been observed that there is approximately a 90% loss of acetylcholine in the brains of people afflicted with Alzheimer’s disease (Boeree, 2009). The α-7 nicotinic acetylcholine receptors (α7- nAChRs) are highly expressed in the hippocampus (Prickaerts et al., 2011). Hippocampal long-term potentiation (LTP) is the constant increase in the efficiency of synaptic transmission. Research supports the hypothesis that α-7 nAChR agonists improve LTP and the formation of long-term memory in animal models due to the activation of the MAPK signaling pathway, with phosphorylation of ERK and CREB. α-7 nAChR agonists also improved learning and memory task performance in mice. With the intention of reducing cognitive impairments and improving memory in those afflicted with Alzheimer’s disease, Marquadraezon will be a partial agonist at the α-7 nACh receptor. This receptor has two pockets in which the drug may bind. Thus, to activate the receptor two molecules must bind. The receptor will be exposed to a low concentration of the high affinity drug and when exposed to both the drug and low affinity acetylcholine, the receptor will be quickly activated (Prickaerts et al., 2011). Thus, the binding of the Marquadraezon with the co-agonist

Related Documents

  • Decent Essays

    Alzheimer's Case Study

    • 1794 Words
    • 8 Pages

    It seemed to be more effective when it was given earlier in the course of the disease like patients with mild Alzheimer’s (Alzheimer’s Treatments: What’s on the Horizon?). Drugs called beta-secretase and gamma-secretase inhibitors are working toward stopping the production of beta-amyloid as well (Alzheimer’s Treatments: What’s on the Horizon?). Some studies are looking at other proteins associated with beta-amyloid, rather than treating the beta-amyloid proteins directly. Beta-amyloid interacts with another protein called Fyn. When together, Fyn causes destruction of synapses in the brain.…

    • 1794 Words
    • 8 Pages
    Decent Essays
  • Decent Essays

    After identifying this amino acid as being a key component to Alzheimer’s disease, researchers were also able to identify what kind of future drug could help with cognitive impairment. The drug that is undergoing further research as a cure for Alzheimer’s disease is solanezumab. Solanezumab is a “monoclonal antibody designed to lower the level of beta-amyloid in the brain” (Alzheimer’s Association, 2016). If research goes well regarding this drug it could lead to a possible cure for the Alzheimer’s…

    • 1022 Words
    • 4 Pages
    Decent Essays
  • Decent Essays

    Alzheimer’s Disease Alzheimer’s, which at its worst case is referred to as dementia, is a progressive disease that eats away at the brain and controls the ability to function (Horr 2015) According to Mitchell Clionsky, this disease is common among people of older age causing a mental dysfunction triggering the ability to think, remember and reason as well as behavioral abilities. (Clionsky 2015) These factors can drastically affect the body emotionally. Some patients get frustrated and mad due to not remembering certain tasks that needed to be completed. It’s definitely not easy to have a disease like this, to forget the memories, the last phone call conversation or to even forget what was consumed for breakfast. People diagnosed will eventually…

    • 1146 Words
    • 5 Pages
    Decent Essays
  • Decent Essays

    Abstract: Binge drinking is a major health problem in the United States resulting in approximately 88,000 deaths per year. One important receptor tyrosine kinase that plays a role in addiction and alcohol dependence is Anaplastic lymphoma kinase (ALK). Specifically, this enzyme is involved in a signaling cascade that relays signals to specific neurons in the nervous system. Experiments analyzing several inhibitors of ALK have found that addiction behaviors, such as cocaine sensitization and binge drinking were reduced after treatment with the inhibitors. Two inhibitors that showed a significant decrease in binge drinking were TAE684 and Alectinib.…

    • 1303 Words
    • 6 Pages
    Decent Essays
  • Decent Essays

    One such inhibitor is geldanamycin (GA). GA increases the expression of HSP70 by inhibiting the interaction between HSP90 and HSF1. GA treatment in animal models of some other neurodegenerative diseases, such as Huntington’s disease and amyotrophic lateral sclerosis (ALS), has given promising results. Unfortunately, there are several problems with the use of GA. It penetrates the blood-brain barrier poorly and its solubility is weak.…

    • 1591 Words
    • 7 Pages
    Decent Essays
  • Decent Essays

    Alzheimer's Disease Study

    • 903 Words
    • 4 Pages

    Genetic mutation is commonly the determinant that causes AD in individuals under 65 while individuals over 65 are predominantly developing Alzheimer 's due to modifications in the brain over several decades (NIH 2016b). In addition, AD causes degeneration of the brain and memory loss due to substantially less synapses and neurons (AA 2016b, Brightfocus Foundation 2016). Neurofibrillary tangles consisting of twisted tau proteins inhibit the brain from receiving nutrients via the microtubule and plaque made of beta-amyloid bundled together blocks communication between neurons (AA 2016b). Individuals who are over 65 years old or have health concerns related the circulatory system have an accelerated deterioration rate (AS 2016). In the early stages of AD, there is a small variation in behaviour and lack of memory, but as the disease progresses over time, their cognitive abilities will worsen (AS 2016).…

    • 903 Words
    • 4 Pages
    Decent Essays
  • Decent Essays

    These include amyloid plaques, neurofibrillary tangles and the loss of connections between the neurons responsible for memory and learning abilities (“NINDS”). In those with Alzheimer’s amyloid plaques interfere with the communication between different cells which damages and destroys brain cells. In a brain affected by neurofibrillary tangles, failure of the transport system occurs when threads of tau protein twist into abnormal tangles inside brain cells (“Alzheimer’s disease”). In the more advanced stages of Alzheimer’s, the brain shrinks in size. The shrinking of the cortex, causes damage to functions such as thinking, planning and remembering.…

    • 1374 Words
    • 6 Pages
    Decent Essays
  • Decent Essays

    What is Alzheimer’s disease? How is Alzheimer’s disease formed? Alzheimer’s disease is a type of dementia that destroys memories, thinking skills, and causes drastic changes in behavior. In which the brain is losing nerve cells also called neurons caused by “Tangles” and “Plaques.” They are both formed up out of two different types of proteins which are called Beta-Amyloid protein and Tau Protein. These proteins are usually formed to help our brain cells’ communication.…

    • 1755 Words
    • 8 Pages
    Decent Essays
  • Decent Essays

    The digestive system is not directly affected by the disease, however problems with swallowing can cause decrease in appetite. The cardiopulmonary system when under the influence of Alzheimer’s causes the person to become more susceptible to pneumonia, hypertension, arthrosclerosis, and strokes. One theory as to why this happens is that when a person is suffering from Alzheimer’s disease their brain does not receive enough blood flow to the brain. The urogenital system of the body suffers in a way that make living daily life difficult; as the disease progressive the person will lose control of their bowels completely. Finally, and most severely affected, is the nervous system.…

    • 1093 Words
    • 5 Pages
    Decent Essays
  • Decent Essays

    Ronald Reagan was diagnosed with Alzheimer 's disease in 1994, which was after his presidential term. Alzheimer 's disease (AD) is an incurable and debilitating chronic progressive neurodegenerative disorder which is the leading cause of dementia worldwide (Kazim and Iqbal, 2016). Many of Reagan’s speech characteristics changed and can be associated with the neurological structures such as the myelination of the neurons as well as specific genes and the thickness of the surrounding cells of the neuron. A Study done on molecular neurodegeneration states, “Finally, we document that the loss of BIN1 significantly correlates with the extent of demyelination in multiple sclerosis lesions” (De Rossi et al, 2016). The study provides information…

    • 1192 Words
    • 5 Pages
    Decent Essays